Ординатура / Офтальмология / Английские материалы / Electrophysiology of Vision_Lam_2005

age-related maculopathy, and bull’s-eye maculopathy. Ophthalmology 2001; 108:2060–2067.

75.Deutman AF. Electro-oculography in families with vitelliform dystrophy of the fovea: detection of carrier state. Arch Ophthalmol 1969; 81:305–316.

76.Franc¸ois J. Vitelliform macular degeneration. Ophthalmologica 1971; 163:312–324.

77.Franc¸ois J, de Rouck A, Fernandez-Sasso D. Electrooculography in vitelliform degeneration of the macula. Arch Ophthalmol 1967; 77:726–733.

78.Sabates R, Pruett RC, Hirose T. The electroretinogram in ‘vitelliform’ macular lesions. Doc Ophthal Proc Ser 1983; 37:93–103.

79.Schwartz LJ, Metz HS, Woodward F. Electrophysiologic and fluorescein studies in vitelliform macular degeneration. Arch Ophthalmol 1972; 87:636–641.

80.Thorburn W, Nordstrom S. EOG in a large family with hereditary macular degeneration. (Best’s vitelliform macular dystrophy) identification of gene carriers. Acta Ophthalmol (Copenh) 1978; 56:455–464.

81.Seddon JM, Sharma S, Chong S, Hutchinson A, Allikmets R,

Adelman RA. Phenotype and genotype correlations in two Best families. Invest Ophthalmol Vis Sci 2003; 110: 1724–1731.

82.Nilsson SE, Skong KO. The ERG c-wave in vitelliform macular degeneration (VMD). Acta Ophthalmol 1980; 58:659–666.

83.Falsini B, Porciatti V, Porrello G, Merendino E, Minnella A, Cermola S, Buzzonetti L. Macular flicker electroretinograms in Best vitelliform dystrophy. Curr Eye Res 1996; 6: 638–646.

84.Scholl HPN, Schuster AM, Vonthein R, Zrenner E. Mapping of retinal function in Best macular dystrophy using multifocal electroretinography. Vis Res 2002; 42:1053–1061.

85.Palmowski AM, Allgayer R, Heinemann-Vernaleken B, Scherer V, Ruprecht KW. Detection of retinal dysfunciton

in vitelliform macular dystrophy using the multifocal ERG (MF-ERG). Doc Ophthalmol 2003; 106:145–152.

86.Weleber RG. Fast and slow oscillations of the electrooculogram in Best’s macular dystrophy and retinitis pigmentosa. Arch Ophthalmol 1989; 107:530–537.

87.Jarc-Vidmar M, Pepovic P, Hawlina M, Brecelj J. Pattern ERG and psychophysical functions in Best’s disease. Doc Ophthalmol 2001; 103:47–61.

88.Goodman G, Ripps H, Siegel IM. Cone dysfunction syndromes. Arch Ophthalmol 1963; 70:214–231.

89.Downes SM, Fitzke FW, Holder GE, Payne AM, Bessant DA, Bhattacharya SS, Bird AC. Clinical features of codon 172 RDS macular dystrophy: similar phenotype in 12 families. Arch Ophthalmol 1999; 117:1373–1383.

90.Wroblewski HJ, Wells JA, III, Eckstein A, Fitzke F, Jubb C, Keen TJ, Inglehearn C, Bhattacharya S, Arden GB, Jay M, Bird AC. Macular dystrophy associated with mutations at codon 172 in the human retinal degeneration slow gene. Ophthalmology 1994; 101:12–22.

91.Heckenlively JR, Weleber RG. X-linked recessive cone dystrophy with tapetal-like sheen: a newly recognized entity with Mizuo–Nakamura phenomenon. Arch Ophthalmol 1986; 104:1322–1328.

92.Berson EL, Gouras P, Gunkel RD. Progressive cone degeneration, dominantly inherited. Arch Ophthalmol 1968; 80:77–83.

93.Kellner U, Klein-Hartlage P, Foerster MH. Cone dystrophies: clinical and electrophysiological findings. Ger J Ophthalmol 1992; 1:105–109.

94.Krill AE, Deutman AF. Dominant macular degenerations: the cone dystrophies. Am J Ophthalmol 1972; 73:352–369.

95.Krill AE, Deutman AF, Fishman M. The cone degenerations. Doc Ophthalmol 1973; 35:1–80.

96.Francois J, de Rouck A, de Laey JJ. Progressive cone dystrophies. Ophthalmologica 1976; 173:81–101.

97.Ripps H, Noble KG, Greenstein VC, Siegel IM, Carr RE. Progressive cone dystrophy. Ophthalmology 1987; 94:1401–1409.

98.Kellner U, Foerster MH. Cone dystrophies with negative photopic electroretinogram. Br J Ophthalmol 1993; 77: 404–409.

99.Mathews GP, Sandberg MA, Berson EL. Foveal cone electroretinograms in patients with central visual loss of unexplained etiology. Am J Ophthalmol 1992; 110:1568–1570.

100.Miyake Y, Ichikawa H, Shiose Y, Kawase Y. Hereditary macular dystrophy without visible fundus abnormalities. Am J Ophthalmol 1989; 108:292–299.

101.Miyake Y, Horiguchi M, Tomita N, Kondo M, Tanikawa A, Takahashi H, Suzuki S, Terasaki H. Occult macular dystrophy. Am J Ophthalmol 1996; 112:644–653.

102.Piao CH, Kondo M, Tanikawa A, Terasaki H, Miyake Y. Multifocal electroretinogram in occult macular dystrophy. Invest Ophthalmol Vis Sci 2000; 41:513–517.

103.Noble KG, Siegel IM, Carr RE. Progressive peripheral cone dysfunction. Am J Ophthalmol 1988; 106:557–560.

104.Pearlman JT, Owen WG, Brounley DW. Cone dystrophy with dominant inheritance. Am J Ophthalmol 1974; 77:293–303.

105.Kondo M, Miyake Y, Kondo N, Ueno S, Takakuwa H, Terasaki H. Peripheral cone dystrophy. A variant of cone dystrophy with predominant dysfunction in the peripheral cone system. Ophthalmology 2004; 111:732–739.

106.Gouras P, Eggers HM, Mckay CJ. Cone dystrophy, nyctalopia, and supernormal rod responses. Arch Ophthalmol 1993; 101:718–724.

107.Pawlyk BS, Sandberg MA, Berson EL. Effects of IBMX on the rod ERG of the isolated perfused cat eye: antagonism with light calcium or l-cis-diltiazem. Vis Res 1991:1093–1097.

108.Hood DC, Cideciyan AV, Halevy DA, Jacobson SG. Sites of disease action in a retinal dystrophy with supernormal and delayed rod electroretinogram b-wave. Vis Res 1996; 36:889–901.

109.Sorsby S, Mason MEJ. A fundus dystrophy with unusual features. Br J Ophthalmol 1949; 33:67–97.

110.Weber BHF, Vogt G, Pruett RC, Sto¨hr H, Felbor U. Mutations in the tissue inhibitor of metaliproteinase-3 (TIMP3) in patients with Sorsby’s fundus dystrophy. Nat Genet 1994; 8:352–356.

111.Anand-Apte B, Pepper MS, Voest E, Montesano R, Olsen B, Murphy G, Apte SS, Zetter B. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3. Invest Ophthalmol Vis Sci 1997; 38:817–823.

112.Clark AF. New discoveries on the roles of matrix metalloproteinases in ocular cell biology and pathology. Invest Ophthalmol Vis Sci 1998; 39:2514–2516.

113.Steen B, Sejersen S, Berglin L, Seregard S, Kvanta A. Matrix metalloproteinases and metalloproteinase inhibitors in choroidal neovascular membranes. Invest Ophthalmol Vis Sci 1998; 39:2194–2200.

114.Capon MR, Marshall J, Kraft JI, Alexander RA, Hiscott PS, Bird AC. Sorsby’s fundus dystrophy—a light and electron microscopic study. Ophthalmology 1989; 96:1769–1777.

115.Capon MRC, Polkingborne PJ, Fitzke FW, Bird AC. Sorsby’s pseudoinflammatory macula dystrophy-Sorsby’s fundus dystrophies. Eye 1988; 2:114–122.

116.Felbor U, Berkowitz C, Klein ML, Greenberg J, Gregory CY, Weber BHF. Sorsby fundus dystrophy: reevaluation of variable expressivity in patients carrying a TIMP3 founder mutation. Arch Ophthalmol 1997; 115:1569–1571.

117.Polkingborne PJ, Capon MRC, Berninger T, Lyness AL, Sehmi K, Bird AC. Sorsby’s fundus dystrophy: a clinical study. Ophthalmology 1989; 96:1763–1768.

118.Cideciyan AV, Pugh EN, Lamb TD, Huang Y, Jacobson SG. Rod plateaux during dark adaptation in Sorsby’s fundus dystrophy and viatamin A deficiency. Invest Ophthalmol Vis Sci 1997; 38:1786–1794.

119.Steinmetz RL, Polkinghorne PC, Fitzke FW, Kemp CM, Bird AC. Abnormal dark adaptation and rhodopsin kinetics in

Sorsby’s fundus dystrophy. Invest Ophthalmol Vis Sci 1992; 33:1633–1636.

120.Jacobson SG, Cideciyan AV, Regunath G, Rodriguez FJ, Vandenburgh K, Sheffield VC, Stone EM. Night blindness in Sorsby’s fundus dystrophy reversed by vitamin A. Nat Genet 1995; 11:27–32.

121.De La Paz MA, Pericak-Vance MA, Lennon F, Haines JL, Seddon JM. Exclusion of TIMP3 as a candidate locus in age-related macular degeneration. Invest Ophthalmol Vis Sci 1997; 38:1060–1065.

122.Carrero-Valanzuela RD, Klein ML, Weleber RG, Murphey WH, Litt M. Sorsby fundus dystrophy: a family with the Ser181Cys mutation of the tissue inhibitor of metalloproteinase 3. Arch Ophthalmol 1996; 114:737–738.

123.Hamilton WK, Ewing CC, Ives EJ, Caruthers JD. Sorsby’s fundus dystrophy. Ophthalmology 1989; 96:1755–1762.

124.Hoskin A, Sehmi K, Bird AC. Sorsby’s pseudoinflammatory macular dystrophy. Br J Ophthalmol 1981; 65:859–865.

125.Clarke MP, Mitchell KW, McDonnell S. Electroretinographic findings in macular dystrophy. Doc Ophthalmol 1997; 92: 325–339.

126.Lip P-L, Good PA, Gibson JM. Sorsby’s fundus dystrophy: a case report of 24 years follow-up with electrodiagnostic tests and indocyanine green angiography. Eye 1999; 13:16–25.

127.Saperstein DA. Advances in macular dystrophies. Int Ophthalmol Clin 1995; 35:19–35.

128.Marmor MF, Byers B. Pattern dystrophy of the pigment epithelium. Am J Ophthalmol 1977; 84:32–44.

129.Sjo¨gren H. Dystrophia reticularis laminae pigmentossae retinae. Acta Ophthalmol 1950; 28:279–295.

130.Slezak H, Hommer K. Fundus pulverulentis. Albrecht von Graefes Arch Klin Exp Ophthalmol 1969; 178:177–182.

131.Deutman AF, van Blommestein JD, Henkes HE, Waardenburg PJ, Solleveld-van Driest E. Butterfly-shaped pigment dystrophy of the fovea. Arch Ophthalmol 1970; 83:558–569.

132.Mesker BP, Oosterhuis JA, Delleman JW. A retinal lesion resembling Sjo¨gren’s dystrophia reticularis laminae pigmentossae retinae. In: Winkelman P, Crone R, eds. Perspectives in Ophthalmology. Amsterdam: Excerpta Medica Foundation Vol. 2, 1970:40–45.

133.Marmor MF, McNamara J. Pattern dystrophy of the retinal pigment epithelium and geographic atrophy of the macula. Am J Ophthalmol 1996; 122:382–392.

134.de Jong PT, Delleman JW. Pigment epithelial pattern dystrophy. Four different manifestations in a family. Arch Ophthalmol 1982; 100:1416–1421.

135.Giuffre G. Autosomal dominant pattern dystrophy of the retinal pigment epithelium. Intrafamilial variability. Retina 1988; 8:169–173.

136.Hsieh RC, Fine BS, Lyons JS. Pattern dystrophies of the retinal pigment epithelium. Arch Ophthalmol 1977; 95:429–435.

137.Gutman I, Walsh JB, Henkind P. Vitelliform macular dystrophy and butterfly-shaped epithelial dystrophy: a continuum? Br J Ophthalmol 1982; 66:170–173.

138.Kim RY, Dollfus H, Keen TJ, Fitzke FW, Arden GB, Bhattacharya SS, Bird AC. Autosomal dominant pattern dystrophy of the retina associated with a 4-base pair insertion at codon 140 in the peripherin=RDS gene. Arch Ophthalmol 1995; 113:451–455.

139.Sears JE, Aaberg TA Sr, Daiger SP, Moshfeghi DM. Splice site mutation in the peripherin=RDS gene associated with pattern dystrophy of the retina. Am J Ophthalmol 2001; 132:693–699.

140.Nichols BE, Sheffield VC, Vandenburgh K, Drack AV, Kimura AE, Stone EM. Butterfly-shaped pigment dystrophy of the fovea caused by a point mutation in codon 167 of the RDS gene. Nat Genet 1993; 3:202–207.

141.Nichols BE, Drack AV, Vandenburgh K, Kimura AE, Sheffield VC, Stone EM. A 2-base pair deletion in the RDS gene associated with butterfly-shaped pigment dystrophy of the fovea. Hum Mol Genet 1993; 2:601–603.

142.Massin P, Virally-Monod M, Vialettes B, Paques M, Gin H, Porokhov B, Caillat-Zucman S, Froguel P, Paquis-Fluckinger V, Gaudric A, Guillausseau P-J. Prevalence of macular pattern dystrophy in maternally inherited diabetes and deafness, GEDIAM GROUP. Ophthalmology 1999; 106: 1821–1827.

143.Daniele S, Carbonara A, Daniele C, Restagno G, Orcidi R. Pattern dystrophies of the retinal pigment epithelium. Acta Ophthalmol Scand 1996; 74:51–55.

144.Duinkerke-Eerola, K U, Pinckers A, Cruysberg JR. Pattern dystrophy of the retinal pigment epithelium. Int Ophthalmol 1987; 11:65–72.

145.Kingham JD, Fenzi RE, Willerson D, Aaberg TM. Reticular dystrophy of the retinal pigment epithelium. A clinical and electrophysiologic study of three generations. Arch Ophthalmol 1978; 96:1177–1184.

146.O’Donnell FE, Schatz H, Reid P, Green WR. Autosomal dominant dystrophy of the retinal pigment epithelium. Arch Ophthalmol 1979; 97:680–683.

147.Shiono T, Ishikawa A, Hara S, Tamai M. Pattern dystrophy of the retinal pigment epithelium. Retina 1990; 104:251–254.

148.Watzke RC, Folk JC, Lang RM. Pattern dystrophy of the retinal pigment epithelium. Ophthalmology 1982; 89: 1400–1406.

149.Forsius H, Krause U, Helve J, Vuopala V, Mustonen E, Vainio-Mattila B, Fellman J, Eriksson AW. Visual acuity in 183 cases of X-chromosomal retinoschisis. Can J Ophthalmol 1973; 8:385–393.

150.George NDL, Yates JRW, Moore AT. Clinical features in affected males with X-linked retinoschisis. Arch Ophthalmol 1996; 114:274–280.

151.de Jong PT, Zrenner E, van Meel GJ, Keunen JE, van Norren D. Mizuo phenomenon in X-linked retinoschisis: pathogenesis of the Mizuo phenomenon. Arch Ophthalmol 1991; 109:1104–1108.

152.Miyake Y, Terasaki H. Golden tapetal-like fundus reflex and posterior hyaloid in a patient with X-linked juvenile retinoschisis. Retina 1999; 19:84–86.

153.Sauer CG, Gehrig A, Warneke-Wittstock R, Marquardt A, Ewing CC, Gibson A, Lorenz B, Jurklies B, Weber BH. Positional cloning of the gene associated with X-linked juvenile retinoschisis. Nat Genet 1997; 17:164–170.

154.Condon GP, Brownstein S, Wang NS, Kearns JA, Ewing CC. Congenital hereditary (juvenile X-linked) retinoschisis. Histologic and ultrastructural findings in three eyes. Arch Ophthalmol 1986; 104:576–583.

155.Kellner U, Bru¨ mmner S, Foerster MH, Wessing A. X-linked congenital retinoschisis. Graefes Arch Clin Exp Ophthalmol 1990; 228:432–437.

156.Peachey NS, Fishman GA, Derlacki DJ, Brigell MG. Psychophysical and electroretinographic findings in X-linked juvenile retinoschisis. Arch Ophthalmol 1987; 105: 513–516.

157.Tanino T, Katsumi O, Hirose T. Electrophysiological similarities between two eyes with X-linked recessive retinoschisis. Doc Ophthalmol 1985; 60:149–161.

158.Bradshaw K, George N, Moore A, Trump D. Mutations of the XLRS1 gene cause abnormalities of the photoreceptor as well as inner responses of the ERG. Doc Ophthalmol 1999; 98:153–173.

159.Eksandh LC, Ponjavic V, Ayyagari R, Bingham BA, Hirlyanna KT, Andre´asson S, Ehinger B, Sieving PA. Phenotypic expression of juvenile X-linked retinoschisis in Swedish families with different mutations in the XLRS1 gene. Arch Ophthalmol 2000; 118:1098–1104.

160.Sieving PA, Bingham EL, Kemp J, Richards J, Hiriyanna K. Juvenile X-linked retinoschisis from XLRS1 Arg213Trp mutation with preservation of the electroretinogram scotopic b-wave. Am J Ophthalmol 1999; 128:179–184.

161.Arden GB, Gorin MB, Polkinghorne PL, Jay M, Bird AC. Detection of the carrier state of X-linked retinoschisis. Am J Ophthalmol 1988; 105:590–595.

162.Shinoda K, Ohde H, Mashima Y, Inoue R, Ishida S, Inoue M, Kawashima S, Oguchi Y. Onand off-responses of the photopic electroretinograms in X-linked juvenile retinoschisis. Am J Ophthalmol 2001; 131:489–494.

163.Alexander KR, Fishman GA, Grover S. Temporal frequency deficits in the electroretinogram of the cone system in X-linked retinoschisis. Vis Res 2000; 40:2861–2868.

164.Piao CH, Kondo M, Nakamura M, Terasuki H, Miyake Y. Multifocal electroretinograms in x-linked retinoschisis. Invest Ophthalmol Vis Sci 2003; 44:4920–4930.

165.Huang S, Wu D, Jiang F, Luo G, Liang J, Wen F, Yu M, Long S, Wu L. The multifocal electroretinogram in X-linked juvenile retinoschisis. Doc Ophthalmol 2003; 106:251–255.

166.Lewis RA, Lee GB, Martonyi CL, Barnett JM, Falls HF. Familial foveal retinoschisis. Arch Ophthalmol 1977; 95:1190–1196.

167.Noble KG, Carr RE, Siegel IM. Familial foveal retinoschisis associated with a rod–cone dystrophy. Am J Ophthalmol 1978; 85:551–557.

168.Shimazaki J, Matsubashi M. Familial retinoschisis in female patients. Doc Ophthalmol 1987; 65:393–400.

169.Yamaguchi K, Hara S. Autosomal juvenile retinoschisis ithout foveal retinoschisis. Br J Ophthalmol 1989; 73: 470–473.

170.Sorsby A, Crick RP. Central areolar choroidal schlerosis. Br J Ophthalmol 1953; 37:129–139.

171.Waardenburg PJ. Angio-schlerose familiale de la choroide. J Genet Hum 1952; 1:83–93.

172.Yanagihashi S, Nakazawa M, Kurotaki J, Sato M, Miyagawa Y, Ohguro H. Autosomal dominant central areolar choroidal dystrophy and a novel Arg195Leu mutation in the peripherin=RDS gene. Arch Ophthalmol 2003; 121:1458–1461.

173.Hughes AE, Lotery AJ, Silvestri G. Fine localisation of the gene for central areolar choroidal dystrophy on chromosome 17p. J Med Genet 1998; 35:770–772.

174.Lotery AJ, Einnis K, Silvestri G, Nicholl S, McGibbon D, Collins AD, Hughes AE. Localisation of a gene for central areolar choroidal dystrophy to chromosome 17p. Hum Mol Genet 1996; 5:705–708.

175.Adachi-Usami E, Murayama K, Yamamoto Y. Electroretinogram and pattern visually evoked cortical potentials in central areolar choroidal dystrophy. Doc Ophthalmol 1990; 75:33–40.

176.Carr RE. Central areolar choroidal dystrophy. Arch Ophthalmol 1965; 73:32–35.

177.Noble K. Central areolar choroidal dystrophy. Am J Ophthalmol 1977; 84:310–318.

178.Ponjavic V, Andreasson S, Ehinger B. Full-field electroretinograms in patients with central areolar choroidal dystrophy. Acta Ophthalmol (Copenh) 1994; 72:537–544.

179.Lotery AJ, Silvestri G, Collins AD. Electrophysiology findings in a large family with central areolar choroidal dystrophy. Doc Ophthalmol 1999; 97:103–119.

180.Lefler WH, Wadsworth JA, Sidbury JB Jr. Hereditary macular degeneration and aminoaciduria. Am J Ophthalmol 1971; 71:224–230.

181.Fetkenhour CL, Gurney N, Dobbie JG, Choromokos E. Central areolar pigment epithelial dystrophy. Am J Ophthalmol 1976; 81:745–753.

182.Frank HR, Landers MBI, Willems RJ, Sidbury JB Jr. A new dominant progressive foveal dystrophy. Am J Ophthalmol 1974; 78:903–916.

183.Small KW, Hermsen V, Gurney N, Fetkenhour CL, Folk JC. North Carolina macular dystrophy and central areolar pigment epithelial dystrophy: one family, one disease. Arch Ophthalmol 1992; 110:515–518.

184.Rabb M, Mullen L, Yelchitis S, Udar N, Small KW. A North Carolina macular dystrophy phenotype in a Belizean family maps to the MCDR1 locus. Am J Ophthalmol 1998; 125: 502–508.